Applied Therapeutics, Inc.
APLT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $119,470 | $282,217 | $28,747 | $229,102 |
| - Cash | $79,398 | $49,898 | $16,657 | $53,888 |
| + Debt | $2,795 | $777 | $1,977 | $2,122 |
| Enterprise Value | $42,867 | $233,096 | $14,067 | $177,336 |
| Revenue | $455 | $9,993 | $0 | $0 |
| % Growth | -95.4% | – | – | – |
| Gross Profit | -$48,289 | -$43,912 | -$441 | $0 |
| % Margin | -10,613% | -439.4% | – | – |
| EBITDA | -$104,298 | -$64,534 | -$82,067 | -$105,617 |
| % Margin | -22,922.6% | -645.8% | – | – |
| Net Income | -$105,624 | -$119,763 | -$82,508 | -$105,584 |
| % Margin | -23,214.1% | -1,198.5% | – | – |
| EPS Diluted | -0.76 | -1.42 | -2.18 | -4.12 |
| % Growth | 46.5% | 34.9% | 47.1% | – |
| Operating Cash Flow | -$84,305 | -$55,173 | -$78,093 | -$90,728 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$84,305 | -$55,173 | -$78,093 | -$90,728 |